Literature DB >> 2262916

Comparison of 4-aminopyridine and tetrahydroaminoacridine on basal forebrain neurons.

W H Griffith1, J A Sim.   

Abstract

This study was designed to investigate the ability of 4-aminopyridine (4-AP) and tetrahydroaminoacridine (THA) to reduce several potassium conductances in cells of the medial septum and nucleus of the diagonal band. Intracellular recording and single electrode voltage-clamp techniques were used in an in vitro brain slice preparation. Both 4-AP (100-300 microM) and THA (300 microM) reduced a transient outward current (A-current), whereas only 4-AP increased the release of spontaneous postsynaptic potentials and significantly prolonged action potential duration. High concentrations of THA (1 mM) were needed to significantly increase action potential duration but these levels of THA were still ineffective in eliciting spontaneous postsynaptic potentials. THA (300 microM), but not 4-AP, had the additional effect of reducing time-dependent membrane rectification (Q-current) in one cell type. Our results demonstrate that both cholinergic and non-cholinergic cells are sensitive to pharmacological concentrations of both compounds.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2262916

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Detection and modulation of acetylcholine release from neurites of rat basal forebrain cells in culture.

Authors:  T G Allen; D A Brown
Journal:  J Physiol       Date:  1996-04-15       Impact factor: 5.182

2.  Gain Modulation of Cholinergic Neurons in the Medial Septum-Diagonal Band of Broca Through Hyperpolarization.

Authors:  Eric D Melonakos; John A White; Fernando R Fernandez
Journal:  Hippocampus       Date:  2016-09-15       Impact factor: 3.899

3.  Investigations into pharmacological antagonism of general anaesthesia.

Authors:  H J Little; A Clark; W P Watson
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 4.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.